CCL2 and COVID-19: As expected, performing TPE decreased the amount of anti-type I IFN auto-antibodies and improved the elimination or limited the production of certain inflammatory mediators (IL-18, IL-7, CCL2, CCL3, etc.)circulating in the blood of COVID-19 patients, compared to ST controls.